The bacterial diagnostics in aquaculture market, valued at approximately USD 3.811.5 million in 2022, is projected to reach USD 4,024.7 Million in 2023. According to a recent report by Future Market Insights (FMI), the market is anticipated to expand at a robust compound annual growth rate (CAGR) of 7.0% from 2023 to 2033, ultimately totaling around USD 7,948.6 Million by 2033.
The surge in seafood demand within the aquaculture sector is a key driver of this growth, as countries worldwide increase their food production capabilities to meet the rising appetite for fish and seafood products. This trend is particularly pronounced in developing nations, where aquaculture is rapidly evolving into a crucial component of food security and economic development.
Competitive Landscape in the Bacterial Diagnostics in Aquaculture Market
Key players in the bacterial diagnostics in aquaculture market focus on research and development for new product designs Also, manufacturers strive to provide cutting-edge technology along with reliable and durable bacterial diagnostics in aquaculture. Furthermore, many companies also focus on strengthening their geographic presence across the globe through partnerships and collaborations with other manufacturers.
Aquasol Corporation, Ziva Impex Pvt Ltd., Aquatic Diagnostics Ltd, Mologic, Biogenuix, Auro Biotechnologies, Enasis Indonesia, Thermo Fisher Scientific, LexaGene, Myron L, and others are some of the leading participants in the bacterial diagnostics in aquaculture market.
- In July 2020, Zoetis Inc., a pharmaceutical firm located in the United States, announced the purchase of Fish Vet Group, a leading finfish health company, as a part of its Pharma division. Zoetis could broaden its regional reach and strengthen its diagnostic and testing services offering as a result of the transaction.
- Atlantic salmon, Nile tilapia, and channel catfish are all caged. These systems and species have benefited from targeted genetic and nutritional breakthroughs, but they are still subject to market volatility, and catastrophic weather events.
On the basis of aquatic animal type, the Global Bacterial Diagnostics in Aquaculture Industry study contains:
- Mackrel
- Carps
- Milkfish
- Sea bream
- Sea bass
- Trout
- Crustaceans
- Other species
On the basis of technique bacterial diagnostics, the Global Bacterial Diagnostics in Aquaculture Industry report covers the key segments, such as
- Histopathology
- Electron microscopy
- Scanning Electron microscopy
- Transmission electron microscopy
- Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- Real-Time PCR
What key insights does the Global Bacterial Diagnostics in Aquaculture Industry research provide?
- Historical and current year revenue of related Global Bacterial Diagnostics in Aquaculture Industry players analyzed at the regional level.
- One by one company profile of prominent stakeholders.
- Analysis of the Global Bacterial Diagnostics in Aquaculture Industry size on the basis of product type and end-use type.
- Accurate Bacterial Diagnostics in Aquaculture market forecast in terms of value and volume in numbers and percentages.
- Demand prospect of each segment covered in the report.
Key Segments for the Bacterial Diagnostics in Aquaculture Market
By Aquatic Animal Type:
- Mackerel
- Carps
- Milkfish
- Sea bream
- Sea bass
- Trout
- Crustaceans
- Other species
By Technique:
- Histopathology
- Electron microscopy
- Scanning Electron microscopy
- Transmission electron microscopy
- Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- Real-Time PCR
- Multiple loop-mediated isothermal amplification PCR
- Quantitative PCR
- Arbitrary Primed PCR
- DNA Probes
- DNA microarrays
- Immunological Diagnostics
- Immunohistochemistry (IHC)
- Immunofluorescent Antibody Test (IFAT)
- Immunochromatography
By Distribution Channel:
- Aquarium store
- E-Commerce
- Company stores
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube